Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast cream in infant atopic dermatitis
NCT06998056Phase 2Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Countries
- 3
01
Overview
A Phase 2 trial of roflumilast vehicle cream in atopic dermatitis (AD), sponsored by Arcutis Biotherapeutics. Started Jun 2025; status: completed.
02
Drugs
roflumilast vehicle cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06998056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06998056.